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Abstract 38 
Introduction 39 
Research into interventions to improve health and wellbeing for older people living in 40 
care homes is increasingly common. Health-Related Quality of Life (HRQoL) is 41 
frequently used as an outcome measure but collecting both self-reported and proxy 42 
HRQoL measures is challenging in this setting. This study will investigate the reliability 43 
of UK care home staff as proxy respondents for the EQ-5D-5L and HowRu measures.  44 
 45 
Methods and Analysis 46 
This is a prospective cohort study of a sub-population of care home residents recruited 47 
to the larger Proactive Healthcare for Older People in Care Homes (PEACH) study. It 48 
will recruit residents ≥ 60 years across 24 care homes and not receiving short stay or 49 
respite care. The sample size is 160 participants. Resident and care home staff proxy 50 
EQ-5D-5L and HowRu responses will be collected monthly for three months. Weighted 51 
kappa statistics and intraclass correlation adjusted for clustering at the care home 52 
level will be used to measure agreement between resident and proxy responses. The 53 
extent to which staff variables (gender, age group, length of time caring, role, how well 54 
they know the resident, length of time working in care homes and in specialist 55 
gerontological practice) influence the level of agreement between self-reported and 56 
proxy responses will be considered using a multilevel mixed-effect regression model. 57 
 58 
Ethics and Dissemination 59 
The PEACH study protocol was reviewed by the UK Health Research Authority and  60 
University of Nottingham Research Ethics Committee and was determined to be a 61 
service development project. We will publish this study in a peer-reviewed journal with 62 
international readership and disseminate it through relevant national stakeholder 63 
networks and specialist societies. 64 
 65 
 66 
 67 
 68 
 69 
 70 
 71 
 72 
 73 
  74 
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Introduction  75 
Long term care facilities in the UK are called care homes, and are classified as either 76 
care homes with or without nursing based upon the availability of registered nurses 77 
on-site (1). The types of residents cared for in both classifications of facility are similar 78 
and all UK care homes are included in the international consensus definition of a 79 
nursing home (2). Around 425,000 people live in care homes in the UK (3) with most 80 
residents requiring care due to disability from long-term conditions. The majority of 81 
residents are aged over 85, 75-80% of residents live with dementia (4), and over half 82 
of residents die within 12 months of admission to care home (5). 83 
 84 
Improving the quality of care for older people in long-term care has become a focus of 85 
attention for health and social care providers, both within the UK and internationally 86 
(2), and an increasing number of evaluative research studies are being published that 87 
test the effectiveness and cost-effectiveness of interventions in this setting. Residents’ 88 
quality of life (QoL) is frequently used as an outcome measure in these studies both 89 
to maintain a patient-centred focus and to facilitate health economic evaluation.  The 90 
prevalent frailty and cognitive impairment in the care home population, however, 91 
means that collecting self-reported QoL measures from residents is challenging. As a 92 
response to this, proxy responses to QoL items have sometimes been used. For these 93 
a consultee, drawn from one of care home staff, or a relative or friend, answers 94 
questions on the resident’s behalf.  Using proxy respondents can be unreliable  in care 95 
home settings. There may be lack of continuity of care home staff contact with 96 
individual residents due to shift working and staff turnover, and family and friends may 97 
not be well placed to judge QoL domains if they visit residents for only short periods 98 
(6). 99 
 100 
The EurQoL questionnaire is a widely-used preference-based health-related quality of 101 
life (HRQoL) measure suitable for use in economic evaluations. The EQ-5D-5L version 102 
measures HRQoL across five domains (mobility, self-care, usual activities, pain, 103 
anxiety/depression) with the scale for each domain ranging from level 1 (no problems) 104 
to level 5 (extreme problems). The responses from the five domains are converted to 105 
QoL index scores (utilities) generated from a given country’s general population (7). 106 
These index scores can be used to calculate quality adjusted life years (QALYs), which 107 
are a measure of the person’s state of health – one QALY equates to one year in 108 
perfect health. QALYs are calculated using the area under the curve (8) defined by 109 
utility scores at the different assessment points over the study period. The cost per 110 
QALY gained from an intervention when compared to usual care is the chosen cost-111 
utility measure for determining eligibility for public support of the intervention through 112 
the UK National Health Service (9).  113 
 114 
The scale for the first version of EQ-5D had only three levels (EQ-5D-3L). EQ-5D-3L 115 
has been shown to have good construct validity for self-report (10), and has been used 116 
to measure QoL of older people living in their own homes and in care homes (11). The 117 
5L version was developed subsequently to deal with identified issues with sensitivity 118 
and a ceiling effect on the EQ-5D-3L which limited its ability to discriminate between 119 
health states, particularly in those with higher quality of life (12). There is also an EQ-120 
5D visual analogue scale (VAS) used to assess overall health status, ranging from 0 121 
(worst imaginable) to 100 (best imaginable). VAS is recognised to have specific 122 
strengths and weaknesses(13) but is recommended to be used routinely alongside 123 
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the self-classification questionnaire by the EuroQoL group because of its usefulness 124 
in establishing global health status(14).  125 
 126 
It is recognised that the EQ-5D, in all its forms, is limited by consequence of being a 127 
generic measure that fails to take account of the difference in what constitutes “quality 128 
of life” in a long-term care setting. It doesn’t take account of shifts in emphasis about 129 
what constitutes wellbeing as residents enter long-term care, which means that social 130 
care related quality of life (SCRQoL) measures such as the Adult Social Care 131 
Outcomes Toolkit (ASCOT) may be preferable in this setting (15-16). A further critique 132 
has been that it fails to separate capability (what a resident is able to do) from 133 
preference (what a resident chooses to do under the circumstances), with the result 134 
that some authors have championed capability-based outcome measures, such as the 135 
ICEpop Capability Measure for Older People (ICECAP-O), in care homes (17-18). 136 
Best practice suggests that, if EQ-5D is used in this setting, it is used in combination 137 
with more specific instruments.  138 
 139 
The R-outcome tool howRu has been specifically designed for use in long term care 140 
settings in order to address quality of life in a straightforward way that is practical with 141 
older people.  HowRu is a Patient Recorded Outcome Measure (PROM) that records 142 
four variables (pain or discomfort, feeling low or worried, limitation in activities, and 143 
dependency on others) related to quality of life at a fixed point in time (“How are you 144 
doing today?”) on a four-point scale (none, slight, quite a lot, extreme) (19, 20). The 145 
HowRu score is calculated by summing up the values for each domain to give a value 146 
on a 13-point scale ranging from 0 (worst) to 12 (best).  The HowRu PROM was  147 
designed with older adults in mind (19,20), and may have a cogency and immediacy 148 
that improves upon some of the measurement uncertainty introduced by the relative 149 
abstraction of the questions included in highly validated general population indices 150 
such as EQ-5D-5L. 151 
 152 
In a comparison with EQ-5D in patients attending a cardiovascular outpatient clinic, 153 
HowRu was reported to have better readability, higher completion rate, wider range of 154 
states used and smaller ceiling effect(17). No national tariffs exist to enable calculation 155 
of HowRu indices that would facilitate its use as a preference-based measure in cost-156 
utility analysis.  Understanding how and whether R outcomes correlate with EQ-5D 157 
scores in the care home setting is, however, helpful when considering additional 158 
information that can help triangulate our understanding of how interventions affect 159 
quality of life in this context. Knowing that HowRu correlates with EQ-5D may provide 160 
further justification for using it in clinical settings where broad judgements about impact 161 
on quality of life have to be made without the need for detailed cost-utility analysis. 162 
 163 
Proxies have been used to capture EQ-5D-3L responses from people with dementia, 164 
although poor agreement between patient and proxy ratings has raised concerns 165 
(15,16) and differences between professional and family carer ratings have led to 166 
questions about the appropriate choice of proxy (16). In a comparison of clinicians and 167 
family carers as proxies, clinician responses had better construct validity in the more 168 
observable domains of mobility and self-care, and family carer responses had better 169 
construct validity in the less observable domains of usual activities and 170 
anxiety/depression (16). There is limited evidence, however, comparing self-reported 171 
and proxy responses to the EQ-5D-5L in care home populations (17).  There is, in 172 
particular, a paucity of data as to how it performs in UK care home populations. This 173 
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is important because institutional care is structured differently between nations, with 174 
differing professional carer competencies, patterns of working and job roles. This 175 
means that carers in different countries will have differential exposure to residents and 176 
different competencies in terms of their ability to interpret residents’ experiences, and 177 
a tool that works for professional proxy response in the US may not, therefore, work 178 
as well in the UK.  179 
 180 
The HowRu, as a recently developed PROM, is yet to be fully evaluated for older 181 
people living in care homes (21). It is not known whether proxy responses in this 182 
setting may be useful in completing HowRU and there are no data on how HowRu 183 
correlates with EQ-5D in the care home populations. 184 
This study seeks to fill these evidence gaps. 185 
 186 
Aim 187 
The Assessing Proxy Reliability In Care home Outcome Testing (APRICOT) study is 188 
a preparatory piece of work for the Proactive Healthcare for Older People Living in 189 
Care Homes (PEACH) study. It aims to examine the level of agreement between the 190 
responses to EQ-5D-5L and HowRu by care home staff and residents, and between 191 
EQ-5D-5L and HowRu as quality of life measures. Findings will assist in the 192 
interpretation of quality of life data gathered for the larger PEACH study. 193 
 194 
Objectives 195 
To determine the level of agreement between: 196 
• Resident EQ-5D-5L and staff-proxy EQ-5D-5L responses 197 
• Resident HowRu and staff-proxy HowRu responses 198 
• Resident EQ-5D-5L and HowRu responses 199 
• Proxy EQ-5D-5L and HowRu responses 200 
Methods  201 
Setting 202 
24 care homes in the East Midlands area of England.  These are long-term care 203 
institutions, housing predominantly older people with frailty who can no longer be 204 
cared for at home.  Detailed descriptions of the UK care home sector and the residents 205 
living within it have been published elsewhere (4). 206 
 207 
Brief description of the Proactive Healthcare in Older Peoples’ Care Homes (PEACH) 208 
study 209 
The PEACH intervention involves using Quality Improvement Collaboratives as a 210 
mechanism to encourage implementation of Comprehensive Geriatric Assessment 211 
(CGA) as a unifying framework for assessment and delivery of healthcare in UK care 212 
homes. CGA is widely recognised as a gold-standard way to deliver care for older 213 
people with frailty (22). The aim of PEACH is to improve quality of care and quality of 214 
life for care home residents.  Outcome data quantifying healthcare resource use and 215 
resident level quality of life will be collected on a monthly basis to assess the impact 216 
of the intervention. 217 
 218 
Two instruments are being used in PEACH to assess residents’ quality of life, the EQ-219 
5D-5L and HowRu. The rationale is that these reflect measurable differences in the 220 
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patient experience that may translate, with some interpretation, into an understanding 221 
of how CGA influences quality of care and general wellbeing. APRICOT has been 222 
designed as a preparatory sub-study within PEACH to better enable interpretation of 223 
proxy EQ-5D-5L and HowRU responses collected as part of outcome measurement. 224 
 225 
Participants  226 
Care home recruitment for PEACH took place between  October 2016 and January 227 
2017, with individual resident recruitment from January 2017. A prospective cohort of 228 
a sub-population of residents will be included in the comparison of proxy and self-229 
report measurement of EQ-5D-5L and HowRu in APRICOT. Residents included in the 230 
study will be  those ≥ 60 years across 24 care homes and not receiving short stay or 231 
respite care .To have a better reflection of self-reported and proxy agreement in a care 232 
home setting we will include residents with and without mental capacity.Care home 233 
managers will provide guidance with regards to residents with and without capacity to 234 
participate. When managers are unsure, researchers will make judgements based on 235 
the framework for mental capacity outlined in the 2005 Mental Capacity Act for 236 
England and Wales (23) and in keeping with the recommendations of that Act for 237 
inclusion research, for residents that lack capacity to provide consent to participation 238 
an appropriate person will be consulted to make a decision with regards to 239 
participation in the study. 240 
 241 
This study will be conducted in parallel to the main PEACH study. In addition to the 242 
routine collection of EQ-5D-5L and HowRu from residents recruited to PEACH, proxy 243 
responses to EQ-5D-5L and HowRu will be gathered from staff. We will include staff 244 
such as care home assistants, care home manager and registered nurses, who 245 
know the resident well. We will exclude staff employed in a supportive role, such as 246 
activity coordinators, since their orientation to supporting residents is more variable. 247 
 248 
Data collection 249 
Data from proxies will be collected on three consecutive months. Due to the high staff 250 
turnover amongst care home staff, and to enable the influence of carer characteristics 251 
on the level of agreement to be estimated, data on the carer will be gathered at each 252 
assessment. Repeated measures are required for the final analysis in the PEACH 253 
study for calculating costs per QALY gained (comparing the intervention with usual 254 
care condition) and understanding how the agreement changes at different time points 255 
is therefore of interest. 256 
 257 
Staff proxies will be asked to consider the proxy-resident’s perspective when 258 
completing the questionnaire using the following statement: “Please rate how you 259 
(staff) think the resident will rate his/her own health-realted quality of life, if the resident 260 
was to communicate” (24). Both self-reported and proxy EQ-5D will be completed on 261 
the same day to minimize any variations in responses. 262 
 263 
The EQ-5D VAS will be used in the study in keeping with the recommendations of the 264 
EuroQoL group. 265 
 266 
Primary analysis 267 
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An overall agreement between the self-reported and staff proxy responses on the 268 
domain levels of the EQ-5D-5L and HowRu will be computed. Weighted kappa statistic 269 
and Intra-class correlation (ICC) will be used to calculate the level of agreement for 270 
categorical and continuous outcomes respectively. All reliability indices will be 271 
calculated at the domain levels and overall index scores/QALYs for the EQ-5D-5L. To 272 
calculate the EQ-5D-5L index scores, responses from the descriptive system will be 273 
transformed into index scores derived from the UK general population. This will be 274 
done using the crosswalk value set (25), which maps the 5L descriptive system data 275 
onto the 3L valuation. 276 
 277 
Weighted kappa helps to distinguish between small and large difference in agreement 278 
ratings assigned to the different levels of each domain but equal importance is given 279 
to disagreement (26, 27). The weighting for kappa will be done using linear weight - 280 
this assigns the same importance to the difference between any two categories within 281 
the response scale (28). The confidence interval for the weighted kappa will be 282 
calculated by bootstrapping in Stata 15 (Statcorp, LLC, 2015) with 1000 replications. 283 
This will be done for each time point. 284 
 285 
The kappa statistic ranges from -1 to 1, and the strength of the agreement will be 286 
interpreted with regards to published guidelines (29) with agreement being:  287 
• Poor, if kappa ≤ 0.00 288 
• Slight, if kappa = 0.00 to 0.20 289 
• Fair, if kappa = 0.21 to 0.40 290 
• Moderate, if kappa = 0.41 to 0.60 291 
• Substantial, if kappa = 0.61 to 0.80 292 
• Almost perfect, if kappa ≥ 0.80 293 
Unadjusted ICC will be calculated using two-way mixed effect ANOVA model to 294 
examine the level of agreement between the self-reported and proxy responses for 295 
the EQ-5D-VAS, EQ-5D index scores and total QALYs. ANOVA models are reported 296 
to be robust to deviations in normality and have been used in other quality of life 297 
agreement studies (16,30).The Bland-Altman graph (plotting the mean difference 298 
between the EQ-5D-5L-S (self-report) and EQ-5D-5L-P (proxy) against the mean of 299 
the two measures) will be constructed to supplement the ICC . 300 
 301 
Analysis will be done at each time point for Kappa and ICC. However, a single ICC 302 
value for QALYs will be calculated for individuals with data on all three consecutive 303 
months as this will be used in practice in the PEACH study, where analysis will be 304 
done on consecutive measures made over time. 305 
 306 
To allow for comparability of the level of agreement at the domain and index score 307 
level; the same benchmarks used for kappa will be used for the ICC. 308 
 309 
Clustering 310 
Clustering will be adjusted for because the calculation of kappa and ICC assumes 311 
independence of observations. In our study, clustering could occur at three levels at 312 
each time point. Firstly, at the care home level, where residents within the same care 313 
home have similar characteristics and are different from those in other care homes. 314 
Secondly, at the individual level, where responses are clustered within each resident 315 
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and lastly, at staff level, where staff members within a care home responds on behalf 316 
of multiple residents. 317 
 318 
The ICC value will be calculated allowing for clustering using a nested two-way 319 
mixed effect model calculated by fitting a 2 level random effect model with a random 320 
effect for care home and individuals.  321 
 322 
A cluster adjusted kappa will be calculated using a variance formula. This will include 323 
calculating kappa and its variance for each care home, then estimating the within 324 
cluster variance	𝜎#$using the average of the individual variances, and between cluster 325 
variance 𝜎%$using the variance of the individual kappa. Using these estimates the 326 
clustered Kappa and its variance will be calculated using the formulas below:  327 
 328 
 329 
Where	 330 𝑛' =	Size of cluster 𝑖  331 𝜌 =	Intra-cluster correlation coefficient for Kappa  332 
 333 
 334 
Variance of the cluster adjusted kappa will be obtained using the equation below 335 
(24): 336 
 337 
 338 
The clustered kappa and its variance will then be divided by the square root of the 339 
number of individuals to get the standard error. The 95% confidence interval will be 340 
calculated using this standard error.  341 
 342 
Cluster adjusted kappa (EQ-5D-5L and HowRu domain levels) and ICC (EQ-VAS and 343 
EQ-5D index scores) will be reported for each time point. However, QALYs will be 344 
presented over time, three months, similar to how it will be calculated in the PEACH 345 
study.      346 
 347 
Sample size calculation 348 
We need a sample size of 160 residents assuming a kappa of 0.145 and a confidence 349 
level width of 0.153 derived from a previous study (16), given that 50% of residents 350 
will have any problems. 351 
 352 
Secondary analyses 353 
The effect of age, sex and length of stay in care home (for residents), length time 354 
working in care of older people/care homes and role/rank (for staff) at baseline on the 355 
difference between staff and proxy EQ-5D-5L-S scores will be analysed using a 356 
multilevel mixed effect regression model. 357 
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 358 
To investigate the reliability of using HowRu as a quality of life measure in the care 359 
home population compared with EQ-5D-5L, we will assess agreement between these 360 
indices using weighted kappa statistics. This will involve testing the level of agreement 361 
between domains with similar construct on both scales (31) as shown in table 1. 362 
 363 
Table 1 - Planned pair-wise alignment of HowRU and EQ-5D-5L domains for agreement analysis using kappa 364 
HowRu domains EQ-5D-5L domains 
Pain or discomfort Pain/discomfort 
Feeling low or worried Anxiety/depression 
Limited in what you can do Mobility 
Self-care 
Usual activities 
Dependent on others Mobility 
Self-care 
Usual activities 
 365 
Patient and Public Involvement 366 
The APRICOT and PEACH studies were developed and designed in discussion with 367 
both Care Home Sector and Patient and Public Involvement (PPI) representatives.  368 
The initial research proposal and protocol was presented, prior to submission for 369 
funding, to the Dementia and Frail Older Person’s PPI group hosted in the Division of 370 
Rehabilitation and Ageing, University of Nottingham.  Amendments were made to the 371 
proposal and protocol in light of their feedback.  The PEACH study team includes 372 
one PPI and two care home sector representatives who are present at all study 373 
management meetings, with oversight for the APRICOT sub-study. We keep all 374 
participating care homes working with PEACH updated through quarterly newsletters 375 
which will include dissemination of our findings in lay terms as these become 376 
available. 377 
 378 
Strengths and Limitations of this study 379 
• To our knowledge, this is the first study to investigate the reliability of staff 380 
proxy using the EQ-5D-5L and HowRu, and the reliability of HowRu as a 381 
quality of life measure in a UK care home setting. 382 
• The scales will be administered to residents and staff on the same day, thus 383 
reducing any variations that will affect the level of agreement.  384 
• Analysing the characteristics of staff respondents will help generate insights 385 
into how proxies might better be selected or prepared to maximise the validity 386 
of proxy responses. 387 
• The use of multiple time points will help increase the sample size and account 388 
for the influence of staff turnover on the quality of proxy-response. 389 
• Working with residents with mental capacity will optimise their responses as a 390 
gold standard against which proxies can be compared.  The way in which staff 391 
interpret quality of life in this more communicative and able group may, 392 
however, be different to the way in which the interpret quality of life in 393 
advanced dementia.  394 
 395 
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